Clincosm LogoSign in Get a demo

neoadjuvant treatment

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Neoadjuvant immunochemotherapy
  • Zhengzhou, Henan, China
    Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 2, 2022

ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC

Recruiting
  • Non Small Cell Lung Cancer Stage III
  • Neoadjuvant Treatment
    • Badalona, Barcelona, Spain
    • +19 more
    Jul 28, 2022

    Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment Trial in Zhuhai (Tislelizumab, Low-dose radiotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Neoadjuvant Treatment
    • Zhuhai, Guangdong, China
      Fifth Affilliated Hospital of Sun Yat-sen University
    Apr 22, 2022

    Neoadjuvant Treatment, Rectal Cancer, Cetuximab Trial in Shanghai (cetuximab+mFOLFOX6, short-course radiotherapy)

    Recruiting
    • Neoadjuvant Treatment
    • +3 more
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Apr 15, 2022

    Neoadjuvant Treatment, Rectal Cancer, Bevacizumab Trial (Bevacizumab+mFOLFOX6)

    Not yet recruiting
    • Neoadjuvant Treatment
    • +3 more
    • (no location specified)
    Oct 28, 2021

    Neoadjuvant Treatment, Rectal Cancer, Anlotinib Trial (Anlotinib+Capeox, Capeox)

    Withdrawn
    • Neoadjuvant Treatment
    • +2 more
    • (no location specified)
    Sep 22, 2021

    Mucosal Melanoma, Neoadjuvant Treatment Trial in Beijing (Lenvatinib, Pembrolizumab)

    Not yet recruiting
    • Mucosal Melanoma
    • Neoadjuvant Treatment
    • Lenvatinib, Pembrolizumab
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Nov 10, 2020

    Rectal Cancer, Radiotherapy, Neoadjuvant Treatment Trial in Bologna (IMRT-SIB plus sequential IG-RT boost)

    Unknown status
    • Rectal Cancer
    • +2 more
    • IMRT-SIB plus sequential IG-RT boost
    • Bologna, BO, Italy
      Radiation Oncology Center, Department of Experimental, Diagnosti
    Mar 26, 2018

    Rectal Tumors, Neoadjuvant Treatment Trial in Goyang, Seongnam, Seoul (Cetuximab, Irinotecan, Capecitabine)

    Unknown status
    • Rectal Neoplasms
    • Neoadjuvant Treatment
    • Cetuximab, Irinotecan, Capecitabine
    • Goyang, Gyeonggi, Korea, Republic of
    • +3 more
    Jul 23, 2007